Legal & General Group PLC Blueprint Medicines Corp Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Legal & General Group PLC holds 97,380 shares of BPMC stock, worth $8.94 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97,380
Previous 97,380
-0.0%
Holding current value
$8.94 Million
Previous $9 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding BPMC
# of Institutions
352Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$613 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$610 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$494 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$364 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$254 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.48B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...